Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Acquisitions (2018 - 2025)

Cumberland Pharmaceuticals' Acquisitions history spans 3 years, with the latest figure at $1.0 million for Q4 2025.

  • For Q4 2025, Acquisitions changed N/A year-over-year to $1.0 million; the TTM value through Dec 2025 reached $2.5 million, changed N/A, while the annual FY2025 figure was $2.5 million, N/A changed from the prior year.
  • Acquisitions for Q4 2025 was $1.0 million at Cumberland Pharmaceuticals, up from $611600.0 in the prior quarter.
  • Across five years, Acquisitions topped out at $13.5 million in Q1 2022 and bottomed at -$326262.0 in Q2 2025.